Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jane J. Border"'
Publikováno v:
Frontiers in Aging, Vol 3 (2022)
Although the causes of cognitive impairment are multifactorial, emerging evidence indicates that cerebrovascular dysfunction plays an essential role in dementia. One of the most critical aspects of cerebrovascular dysfunction is autoregulation of cer
Externí odkaz:
https://doaj.org/article/bef8919a9b214ddbbdc65b9a4ecda7a2
Autor:
Shaoxun Wang, Feng Jiao, Jane J. Border, Xing Fang, Reece F. Crumpler, Yedan Liu, Huawei Zhang, Joshua Jefferson, Ya Guo, Parker S. Elliott, Kirby N. Thomas, Luke B. Strong, Austin H. Urvina, Baoying Zheng, Arjun Rijal, Stanley V. Smith, Hongwei Yu, Richard J. Roman, Fan Fan
Publikováno v:
Am J Physiol Heart Circ Physiol
Diabetes mellitus (DM) is a leading risk factor for age-related dementia, but the mechanisms involved are not well understood. We previously discovered that hyperglycemia induced impaired myogenic response (MR) and cerebral blood flow (CBF) autoregul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d07727f0fc162dfb86861b8b28c0c48
https://doi.org/10.1152/ajpheart.00438.2021
https://doi.org/10.1152/ajpheart.00438.2021
Autor:
Xing Fang, Chengyun Tang, Huawei Zhang, Jane J. Border, Yedan Liu, Seung Min Shin, Hongwei Yu, Richard J. Roman, Fan Fan
Alzheimer’s Disease (AD) is a global healthcare crisis. The TgF344-AD rat is an AD model exhibiting age-dependent AD pathological hallmarks. We confirmed that AD rats developed cognitive deficits at 6 months without alteration of any other major bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27611877917d516a2d16eabd55a05893
https://doi.org/10.1101/2022.12.29.522215
https://doi.org/10.1101/2022.12.29.522215
Publikováno v:
Alzheimer's & Dementia. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ce0769ffeb6c9875a7a30cddb1af17b
https://doi.org/10.1002/alz.066929
https://doi.org/10.1002/alz.066929
Publikováno v:
GeroScience
Diabetes, hypertension, and aging are major contributors to cardiovascular and chronic kidney disease (CKD). Sodium/glucose cotransporter 2 (SGLT2) inhibitors have become a preferred treatment for type II diabetic patients since they have cardiorenal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c40f69d36470cfc78eae80ef8a8fe1e9
https://europepmc.org/articles/PMC9768063/
https://europepmc.org/articles/PMC9768063/
Autor:
Xing Fang, Huawei Zhang, Jane J. Border, Patrice L. Rivers, Luke B. Strong, Jonita Cooper, Reece F. Crumpler, Kirby N. Thomas, Richard J. Roman, Fan Fan
Publikováno v:
The FASEB Journal. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::452e56b97a0494de1e06b31b3d2d1fac
https://doi.org/10.1096/fasebj.2022.36.s1.r2710
https://doi.org/10.1096/fasebj.2022.36.s1.r2710